Expected Delivery: 3-4 Days
Business Hours: Monday - Friday: 9 AM - 6 PM EST
David Fuller
Last Updated On: September 18, 2024
Osteoarthritis affects over 500 million people worldwide, making it one of the leading causes of disability. This degenerative joint disease causes pain, stiffness, and reduced mobility, significantly impacting the quality of life. With aging populations and rising obesity rates, the prevalence of osteoarthritis is expected to grow.
Orthovisc and Synvisc are two widely used viscosupplements designed to treat osteoarthritis. These treatments aim to restore the natural lubricating properties of joint fluid, helping to reduce pain and enhance mobility. Understanding their differences is crucial for patients and healthcare providers to make informed treatment choices.
This article will compare Orthovisc vs Synvisc, examining their features, benefits, and uses to help you decide which option may be best for you.
About: Operating since 2016, Med Supply Solutions is known for being one of the industry’s top and trusted suppliers of cosmetic and viscosupplementation products. If you’re looking to buy Orthovisc online, contact our sales department for more information.
Viscosupplements are injectable treatments that contain hyaluronic acid, a substance naturally found in joint fluid. These injections are designed to replenish and enhance the synovial fluid within the joints, which often becomes degraded in individuals with osteoarthritis.
The primary purpose of viscosupplements in osteoarthritis treatment is to restore the natural lubrication and cushioning of the joint. By improving the quality of the joint fluid, viscosupplements help reduce pain, improve mobility, and enhance overall joint function.
They are commonly used when other treatments, like pain relievers or physical therapy, have not provided adequate relief. They offer a non-surgical option to manage osteoarthritis symptoms and improve a patient’s quality of life.
Orthovisc works by mimicking and restoring the natural synovial fluid within the joint, reducing inflammation, friction, and pain associated with osteoarthritis. The treatment typically involves three to four injections administered directly into the knee over several weeks. For those wondering, “Are Orthovisc injections painful?“ some discomfort may occur during administration, but most patients find the procedure manageable.
Orthovisc’s higher concentration of sodium hyaluronate compared to other viscosupplements may provide longer-lasting relief, resulting in smoother joint movement and improved quality of life for patients with osteoarthritis.
Synvisc works by restoring the natural viscoelastic properties of joint fluid, providing shock absorption and reducing friction between the bones. By enhancing the lubrication of the joint, Synvisc helps alleviate pain and improves mobility, making it an essential option for viscosupplementation therapy in osteoarthritis management.
Clinical trials have shown that Orthovisc, a high molecular weight hyaluronan, provides significant pain relief and improved joint function for up to six months in patients with knee osteoarthritis. A multicenter, double-blind, randomized trial compared Orthovisc to corticosteroid injections in shoulder osteoarthritis, demonstrating its efficacy and safety.
Synvisc (Hylan G-F 20) has been extensively studied for its effectiveness in treating knee osteoarthritis. Clinical trials have shown that Synvisc can deliver pain relief for up to six months, with significant improvements observed as early as one week after the first injection. In head-to-head trials, Synvisc demonstrated superior pain relief compared to other viscosupplements like Hyalgan.
To effectively manage osteoarthritis, it’s essential to understand the dosage schedules and injection protocols for viscosupplements like Orthovisc and Synvisc. Here’s a concise overview:
Both treatments involve direct intra-articular injections into the knee joint. Dosage and molecular properties vary, influencing patient outcomes and efficacy.
Orthovisc is generally considered safe for most patients; however, it should not be used by individuals with allergies to avian products, as it is derived from bacterial fermentation.
Synvisc is also safe for most patients but should be avoided by those with known allergies to avian proteins due to its origin from chicken combs.
Below are the common side effects associated with each treatment:
Both treatments are generally well-tolerated, but patients should be aware of these side effects and consult their healthcare provider if symptoms persist or worsen.
Orthovisc and Synvisc offer several advantages for treating osteoarthritis, making them valuable options in viscosupplementation therapy. Each has unique benefits tailored to different patient needs, which can help achieve effective pain relief and improved joint function. Understanding these advantages can aid healthcare professionals in selecting the most suitable treatment for their patients.
Orthovisc and Synvisc are viscosupplements used in osteoarthritis treatment, each with distinct compositions, molecular properties, and dosing requirements. Orthovisc contains highly purified sodium hyaluronate from non-animal sources, while Synvisc is derived from chicken combs and chemically modified to enhance its properties.
Although both offer similar efficacy in relieving joint pain and improving mobility, their safety profiles and potential side effects differ. Healthcare providers should carefully evaluate patient-specific factors, such as allergies, treatment goals, and individual responses, to determine the most suitable option for managing osteoarthritis effectively.
Orthovisc and Synvisc are injectable treatments used to relieve knee pain caused by osteoarthritis. They both contain hyaluronic acid, which helps lubricate and cushion the joints.
Common side effects of Orthovisc include joint pain, stiffness, swelling, itching, and redness at the injection site. Some patients may also experience headaches or dizziness.
The Orthovisc injection procedure can cause some discomfort, but it is generally well-tolerated by most patients. Your healthcare provider may use a local anesthetic to minimize any pain during the injection.
WHO. Osteoarthritis. www.who.int. Published July 14, 2023. https://www.who.int/news-room/fact-sheets/detail/osteoarthritis
He Y, Jiang W, Wang W. Global burden of osteoarthritis in adults aged 30 to 44 years, 1990 to 2019: results from the Global Burden of Disease Study 2019. BMC musculoskeletal disorders. 2024;25(1). doi:https://doi.org/10.1186/s12891-024-07442-w
Products
Cart
Log In
Newsletter
Subscribe for exclusive offers and updates on new arrivals
Share feedback at:
Working Hours
Monday to Friday: 9 AM to 6 PM EST
The Most Popular Brands
Med Supply Solutions
Support
Copyright 2024. Med Supply Solutions